|3Mar 13, 5:06 PM ET

ModernaTX, Inc. 3

3 · Carisma Therapeutics Inc. · Filed Mar 13, 2023

Insider Transaction Report

Form 3
Period: 2023-03-07
Holdings
  • Common Stock

    5,059,338
Footnotes (1)
  • [F1]Pursuant to a reverse-merger transaction consummated on March 7, 2023, the Reporting Person became the beneficial owner of 12.57% of the Issuer's total shares outstanding.

Documents

1 file
  • 3
    doc1.xmlPrimary

    FORM 3